★★★★★ 1,000+ 5 Star Reviews
Pure ingredients
Raw ingredients. Ancient wisdom. Modern results. Every product contains only what nature intended:
- Grass-fed tallow rich in bioavailable nutrients
- Raw honey and adaptogenic herbs in their purest form
- Regeneratively sourced proteins, never denatured
- Zero synthetic additives or lab-made fillers
Small-batch wellness our ancestors would recognize. Because when you honor nature's integrity, your body knows the difference.
Let customers speak for us
Why Purishh?
Pure Ingredients
Handpicked and ethically sourced from trusted, natural farms.
Effective Results
Each product is designed to protect, nourish, and enhance your skin’s natural balance.
Holistic Wellness
Embrace a balanced lifestyle with supplements and creams that work in harmony with your body.
Frequently Asked Question
What makes Purishh products different from conventional supplements or skincare?
What makes Purishh products different from conventional supplements or skincare?
Purishh’s mission is to return to the raw, unprocessed power of nature. Every product is formulated with 100 % natural ingredients and no synthetic preservatives, fillers, or dyes. For example, the Raw Honey Butter contains whipped Wagyu beef tallow, cold‑pressed olive and coconut oils, mango butter, raw honey and beeswax – it moisturizes deeply and can even replace conventional lotion. The Raw Tallow Sunbalm uses grass‑fed tallow, non‑nano zinc oxide and organic oils to provide mineral sun protection while nourishing the skin. Purishh’s Protein Powder combines grass‑fed whey and hydrolyzed collagen with organic superfoods to deliver 26 g of easily digestible protein with zero added sugar. Across their range, Purishh keeps ingredient lists short and transparent, using only what is necessary to support health and well‑being.
Are Purishh’s ingredients ethically and sustainably sourced?
Are Purishh’s ingredients ethically and sustainably sourced?
Yes. The founders emphasize sustainable sourcing and ethical treatment of animals and land. Tallow for the skincare range is hand‑sourced from 100 % grass‑fed, Wagyu, halal cattle in New Zealand, ensuring humane slaughter and optimal nutrient quality. Olive and coconut oils are single‑origin, cold‑pressed. The whey in Purishh protein powder comes from grass‑fed cows raised without hormones or antibiotics, and the collagen is hydrolyzed for better absorption. These practices mean customers receive products that are both pure and sustainable.
Why does Purishh use beef tallow in its skincare products?
Why does Purishh use beef tallow in its skincare products?
Grass‑fed beef tallow is biocompatible with human skin; its fatty‑acid profile closely resembles natural sebum, so it’s absorbed efficiently. Properly rendered tallow is a vitamin powerhouse, naturally supplying vitamins A, D, E, and K that support cell turnover, immune function, and antioxidant protection. Tallow also contains oleic, stearic and palmitic acids that strengthen the skin’s barrier, calm inflammation and maintain moisture. Grass‑fed tallow offers a high concentration of conjugated linoleic acid (CLA), an anti‑inflammatory fatty acid. These nutrients collectively help Purishh’s Raw Honey Butter and Raw Tallow Sunbalm to moisturize, nourish and protect the skin without clogging pores or causing irritation.
How is Purishh protein powder different, and why is it easy to digest?
How is Purishh protein powder different, and why is it easy to digest?
Many conventional protein powders use cheap sources and add artificial thickeners or sweeteners that cause bloating and digestive discomfort. Purishh starts with grass‑fed whey processed via cold‑filtration, which preserves natural enzymes and bioactive peptides that aid digestion. It also adds hydrolyzed bovine collagen to support joints, skin and gut health. The powder uses organic monk fruit for sweetness and contains no carrageenan, gums, sucralose or artificial preservatives, so it mixes smoothly and is gentle on the stomach. Each serving provides 26 g of complete protein with only 1 g of fat and zero sugar, making it suitable for keto, gluten‑free and non‑GMO diets.
What are Purishh Electrolytes, and how do they support hydration?
What are Purishh Electrolytes, and how do they support hydration?
Purishh’s Electrolytes formula offers clean hydration without the artificial colors and preservatives found in many sports drinks. Each serving includes over 800 mg of unrefined Himalayan salt, providing sodium and trace minerals, plus magnesium malate and potassium chloride. Organic fruit powders (raspberry or lemon‑lime) and monk fruit sweetener give a natural flavor without sugar. The formula helps replenish electrolytes lost through exercise, supports muscle function, and is keto‑friendly.
What is Raw Shilajit, and how should it be used?
What is Raw Shilajit, and how should it be used?
Raw Shilajit is a resin harvested from high‑altitude Himalayan rocks. It forms from decomposed plant material and is rich in minerals and fulvic acid. Traditionally used as an adaptogen, Shilajit helps boost energy, improve stamina and support overall health. Purishh provides 100 % pure Himalayan shilajit. Users typically dissolve a pea‑sized amount in warm water, tea or milk. Due to its potent minerals, start with a small dose and consult a healthcare professional if you have existing medical conditions.
What is the Ishh Leaky Gut Protocol?
What is the Ishh Leaky Gut Protocol?
The Ishh Leaky Gut Protocol is a step‑by‑step program designed to help restore gut health naturally. It includes dietary recommendations, lifestyle tips and natural supplements to support the intestinal lining. The protocol focuses on removing irritants, replenishing beneficial bacteria and repairing the gut barrier. It is not a medical treatment, so customers with chronic digestive issues should consult a healthcare professional before starting.
How should I store Purishh products?
How should I store Purishh products?
Store supplements and protein powders in a cool, dry place away from direct sunlight. Skincare products like Raw Honey Butter and Raw Tallow Sunbalm are natural and free from artificial stabilizers; keeping them at room temperature helps maintain texture. If you live in a hot climate, refrigerating tallow‑based balms can prevent melting. Always use clean hands or a spatula to avoid introducing bacteria.
When will my order ship, and how long will delivery take?
When will my order ship, and how long will delivery take?
Purishh asks customers to allow 2–3 business days for processing and production before an order ships. Once dispatched, average transit times are 7–10 business days; however, natural disasters, holidays and weather can cause delays. Free standard shipping is offered on orders over US$150 (or equivalent), and shipping costs for smaller orders are calculated at checkout. Purishh cannot guarantee exact delivery dates because delivery is ultimately the responsibility of the shipping carrier.
Can I subscribe and save on regular purchases?
Can I subscribe and save on regular purchases?
Yes. Purishh offers a subscription program for products like protein powder. Subscribing gives 10 % off the regular price, and you can choose delivery intervals (e.g., monthly). Subscriptions auto‑renew, but you may skip or cancel at any time through your account.
Are Purishh products allergen‑free or suitable for special diets?
Are Purishh products allergen‑free or suitable for special diets?
Purishh formulates products without common synthetic additives, but some items may contain potential allergens. The protein powder contains whey (a dairy product) and collagen derived from bovine sources; it is unsuitable for vegans or those with dairy allergies. The Electrolytes formula is gluten‑free, sugar‑free and keto‑friendly. Always review ingredient lists carefully and consult your healthcare provider if you have specific allergies or dietary restrictions.
Where are Purishh products made?
Where are Purishh products made?
Purishh sources ingredients globally, such as New Zealand Wagyu tallow and Himalayan shilajit, but manufactures products in small batches under rigorous quality control. By keeping production small and hands‑on, Purishh can maintain freshness and ensure every batch meets the highest standards.
Pür Insights
Creatine for Women: Why the Research Finally Caught Up
Creatine for Women: Why the Research Finally Caught Up If you have read anything about creatine and women in the past two years, you have encountered one specific statistic: women have 70 to 80 percent lower endogenous creatine stores than men. It appears in nearly every article on the subject, usually in the first few paragraphs, usually as the justification for why women should supplement. The statistic is real. It is not marketing. It comes from a peer-reviewed review paper, and the sentence reads almost exactly as it gets quoted. What almost nobody quotes is the sentence that appears two paragraphs later in the same paper, which changes how that first number should be understood. This post covers both, along with what the research on creatine in women actually establishes, where it is genuinely strong, and where it remains thin enough that honest writing has to say so. The source everyone cites The 70 to 80 percent figure traces to Smith-Ryan, Cabre, Eckerson, and Candow, "Creatine Supplementation in Women's Health: A Lifespan Perspective," published in Nutrients in 2021, volume 13, issue 3, article 877. It is an open-access paper, and anyone can read it in full. The relevant passage states that creatine characteristics vary between males and females, with females exhibiting 70 to 80 percent lower endogenous creatine stores compared to males. The same review notes that females have also been reported to consume significantly lower amounts of dietary creatine than males, and concludes from these two observations that females may benefit from supplementation as a means of increasing endogenous stores. That is an accurate summary of what the paper says, and it is a reasonable starting point for a conversation about creatine and women. The problem is where most articles stop. The sentence that gets left out Within the same section of the same review, the authors also note that females have higher reported resting intramuscular creatine concentrations, by roughly 10 percent. Read those two findings together and a more precise picture emerges. Total endogenous creatine stores are substantially lower in women. Creatine concentration per unit of muscle is reportedly slightly higher. Both can be true at once, and the reason is straightforward once you know where creatine lives in the body. Roughly 95 percent of the body's creatine sits in skeletal muscle. Total stores are therefore driven overwhelmingly by how much skeletal muscle a person has. Men, on average, carry more muscle mass. They therefore hold more total creatine. That is a statement about body composition, not about how depleted the tissue itself is. This matters because of how the 70 to 80 percent figure typically gets deployed. The popular argument runs: women are severely depleted, therefore they have enormous headroom, therefore they will respond more dramatically to supplementation than men would. That argument rests entirely on the first finding and is weakened considerably by the second. If concentration within the tissue is comparable or slightly higher, the "massive untapped headroom" framing is doing more work than the data supports. None of this means creatine is not worth taking. It means the most-repeated reason for taking it is not quite the reason it is usually presented as, and the actual case is different. So what is the honest case? Several genuine, separately supportable reasons emerge from the literature. Dietary intake is genuinely lower. The same 2021 review notes that women consume significantly less dietary creatine than men. Creatine comes almost exclusively from animal protein, primarily meat and fish, and the body can also synthesize it endogenously from arginine, glycine, and methionine, though that synthesis depends on adequate protein intake. Lower dietary intake is a real gap, and it is a more defensible reason to supplement than a contested claim about depletion. The research base was built on men. This is the most substantive point, and it is the actual reason this topic has become a research priority. For decades, creatine studies were conducted predominantly on male participants. Early work in women frequently overlooked menstrual cycle variability entirely, which means findings from those studies carry uncertainty that was never measured. The correction of that imbalance is what "the research finally caught up" actually refers to. Hormonal fluctuations plausibly affect creatine metabolism. A 2025 narrative review by Smith-Ryan, DelBiondo, Brown, Kleiner, Tran, and Ellery, published in the Journal of the International Society of Sports Nutrition, examined this directly across the female lifespan. The review describes how hormonal changes through the menstrual cycle, pregnancy, and menopause can influence creatine synthesis, transport, and creatine kinase expression, and notes that these factors may in turn affect how supplementation works. This is a mechanistically coherent basis for expecting sex-specific differences, and it is the foundation of the current research direction. What the evidence actually supports Sorting the findings by strength is more useful than listing them all as equivalent. Strength and exercise performance in pre-menopausal women. This is the most solid ground. The 2021 review concluded that creatine supplementation among pre-menopausal females appears effective for improving strength and exercise performance. The 2025 review similarly reported positive effects on muscle strength, exercise performance, and body composition, particularly when combined with resistance training. That last qualifier matters and recurs throughout this literature. Creatine's benefits show up most consistently alongside resistance training, not as a standalone intervention. It supports a training stimulus rather than substituting for one. Post-menopausal muscle size and function. The 2021 review found that post-menopausal females may experience benefits in skeletal muscle size and function when consuming high-dose creatine, specifically 0.3 grams per kilogram of body weight per day, for at least seven consecutive days. For a 70-kilogram woman that works out to roughly 21 grams daily, which is a loading-phase dose rather than a standard maintenance dose, and worth noting precisely because it differs from the routine 3 to 5 grams most people take. One example cited in that review, work by Neves and colleagues, used a loading phase of 20 grams daily for seven days followed by a maintenance phase of 5 grams daily for 79 days, alongside 12 weeks of supervised lower-limb resistance training. Bone health: genuinely less clear. The 2021 review's abstract describes favorable effects on bone when creatine is combined with resistance training in post-menopausal women. Elsewhere in the same paper, discussing specific findings, the text states that creatine supplementation alone or in combination with resistance training appears to provide no benefits in bone physiology in post-menopausal females. We are flagging that discrepancy rather than picking whichever version is more convenient. What can be said confidently is that bone evidence in this population is less consistent than muscle evidence, and anyone citing creatine as an established bone intervention for post-menopausal women is ahead of what this particular review actually establishes. Perimenopause specifically: the data is limited, and the reviews say so. This is worth stating plainly because perimenopause is where a great deal of current creatine marketing is aimed. The 2025 review's own conclusion notes that while emerging evidence suggests benefits during pregnancy and post-menopause, data on perimenopausal women remains limited, and identifies perimenopause explicitly as a target for future research. The mechanistic reasoning for why perimenopause might matter is coherent. The direct evidence in that specific population is not yet there. Both things are true, and content that presents perimenopausal creatine benefits as established is overstating the current literature. Mood and cognition: promising, early, and worth calibrating Both reviews discuss potential effects on mood and cognitive function, with the 2025 review noting creatine may improve mood and cognitive function and potentially alleviate symptoms of depression. Earlier work highlighted this application particularly in women. This is genuinely interesting research, and there is a plausible mechanism behind it, since the brain is a substantial consumer of energy and creatine participates in cellular energy regeneration in neural tissue as it does in muscle. It also requires the same calibration we have applied elsewhere. In November 2024, the European Food Safety Authority's expert panel evaluated a health claim application linking creatine supplementation to improved cognitive function, reviewed 21 human intervention studies, and concluded that a cause-and-effect relationship had not been established. Notably, Darren Candow, a co-author on the 2021 women's health review and one of the field's more prolific researchers, publicly agreed that decision was justified given the current body of evidence. So: real mechanism, genuine research interest, encouraging early signals, and a formal regulatory determination that causation is not established. Anyone presenting creatine as a proven cognitive or mood intervention for women is describing a hypothesis as a conclusion. That does not make it uninteresting. It makes it unfinished. The bloating and water weight question This is the objection that keeps more women from trying creatine than any other, and it is one place where the research is genuinely reassuring rather than equivocal. A randomized controlled trial by Moore, Gordon, Cabre, Hackney, and Smith-Ryan, published in Nutrients in 2023, volume 15, issue 2, article 429, examined changes in fluid distribution across menstrual phases with creatine supplementation. The finding, contrary to the common assumption, was that there was no demonstrated significant increase in body mass in women after creatine monohydrate supplementation in any phase of the menstrual cycle. That is a direct test of the specific fear, in the specific population, across the specific variable people worry about, and it did not find the effect. It is one study rather than a body of replicated work, and worth holding with appropriate weight for that reason, but it is a considerably better answer than the anecdote-versus-anecdote arguments this question usually generates. Pregnancy: interesting research, not a recommendation The 2021 Muccini paper, "Creatine Metabolism in Female Reproduction, Pregnancy and Newborn Health," published in Nutrients, was the first to propose creatine as an essential dietary metabolite of pregnancy, describing its role in placental health and fetal growth and metabolism. This is legitimate, serious research. It is also explicitly not a basis for supplementing during pregnancy. The 2021 lifespan review states directly that there are no human studies to date evaluating the effect of creatine monohydrate supplementation during pregnancy. Mechanistic interest and demonstrated safety in a specific population are different things, and the second has not been established here. Anyone who is pregnant, trying to become pregnant, or breastfeeding should treat this as a conversation for their obstetric provider rather than something to act on from a supplement article, including this one. Practical guidance, based on what the research used For general use in women outside the specific post-menopausal high-dose protocols described above, the standard 3 to 5 grams daily of creatine monohydrate is what the broader literature supports, and no loading phase is required. Loading reaches saturation faster, over roughly a week rather than three to four weeks, but arrives at the same endpoint. Timing is not a meaningful variable. Creatine works by building and maintaining saturated stores over time rather than through an acute effect, which means consistency matters considerably more than which hour of the day you take it. Creatine monohydrate is the form with the research behind it. The newer forms marketed as upgrades, including HCl and various proprietary versions, have not demonstrated superiority over monohydrate in head-to-head research, and monohydrate remains both the most studied and the least expensive option. And because supplements are not reviewed for contents before they reach a shelf, third-party verification of what is actually in the container is worth confirming regardless of which brand you choose. Recent market analysis found that third-party testing and clinical positioning are now outperforming raw review volume as purchase drivers in this category, which suggests buyers have started asking that question themselves. The honest summary The 70 to 80 percent figure is real, sourced, and accurately quoted. It is also routinely used to support a conclusion the underlying data does not quite reach, because the same review reports that intramuscular creatine concentration is slightly higher in women, and total stores are largely a function of muscle mass rather than tissue-level depletion. The genuine case for creatine in women rests on different ground: lower dietary intake, a research base historically built on men that is only now being corrected, and hormonal influences on creatine metabolism that are mechanistically coherent and actively being studied. The evidence is strongest for strength and exercise performance alongside resistance training, and for muscle size and function in post-menopausal women at higher doses. It is less consistent for bone. It is explicitly limited in perimenopause, according to the reviews themselves. It is early and formally unestablished for cognition and mood. And it does not support the water-weight concern that keeps many women from trying it in the first place. That is a more qualified picture than the one currently circulating, and it is the one the published research actually supports. The research did finally catch up. What it found is more specific, and more interesting, than the headline statistic suggests.
Learn moreEverything We've Lab-Tested So Far: A Plain-English Recap
Everything We've Lab-Tested So Far: A Plain-English Recap We've referenced individual lab results across a lot of posts by now, usually one product at a time, in the context of whatever ingredient that post was about. This post puts all of it in one place, organized honestly, including the parts where our documentation is stronger and the parts where it's weaker. That last point matters, so it's worth stating clearly up front: not all of the testing behind our catalog is the same kind of testing. Some of it is finished-product analysis commissioned from an independent accredited laboratory. Some of it is documentation issued by our manufacturer that relays supplier data. Some of it is raw material certification from an ingredient supplier before that ingredient ever reached a finished product. These are genuinely different things, and a recap that presented them all as equivalent would be misleading regardless of how good the individual numbers look. So this is organized by documentation strength rather than by product category, from strongest to weakest. How to read a lab document, briefly Three things determine how much weight a certificate of analysis actually carries. Who ran the test matters most. An accredited independent laboratory, one with no financial stake in the outcome and external validation of its technical competence, produces a different quality of evidence than an internal quality control department or a supplier vouching for its own material. The recognized standard for laboratory competence is ISO/IEC 17025, granted by accrediting bodies such as A2LA, the American Association for Laboratory Accreditation, or PJLA, Perry Johnson Laboratory Accreditation. What was tested matters next. Heavy metal screening, microbial safety, and potency verification are three separate analyses answering three separate questions. A document covering one says nothing about the others. And the specification matters. A result reported against a defined numerical limit tells you whether something passed. A result reported without a limit tells you what was found but leaves the interpretation to you. Both appear in our documentation, and the difference is worth knowing. Tier one: independently commissioned finished-product testing This is the strongest documentation we have, and it covers our protein and electrolyte products. Vanilla Protein Powder, lot L250409. Tested by Delta Labs of South Florida Corp, an ISO/IEC 17025:2017 accredited laboratory operating under PJLA accreditation number 114871, on finished product received April 22, 2025. Protein content was verified at 23.0 grams per 29.95 gram serving using the Kjeldahl method, which is the recognized analytical standard for protein determination via nitrogen analysis rather than a calculated figure from the ingredient list. The full nutritional panel was measured directly: saturated fat at 1.09 grams per serving and trans fat at 0.08 grams per serving by gas chromatography with flame ionization detection, cholesterol at 22.32 milligrams per serving by the same method, total carbohydrates at 4.67 grams by high performance liquid chromatography, total dietary fiber at 1.73 grams by AOAC method 985.29, total sugars at 0.99 grams by HPLC with refractive index detection, and sodium at 50.65 milligrams by inductively coupled plasma analysis. Heavy metals came back at or below the detection floor. Lead, arsenic, and mercury each measured below 0.00003 milligrams per serving. Cadmium measured at 0.000009 milligrams per serving. Combined heavy metals came in under the specification of not more than 0.2995 milligrams per serving. Microbial testing followed USP 43 chapters 2021 and 2022. Total aerobic plate count came back at 30 colony forming units per gram against a limit of not more than 10,000. Yeast and mold came back below 10 CFU per gram against a limit of 1,000. E. coli, Salmonella, Staphylococcus aureus, and Pseudomonas aeruginosa all returned negative. Bile tolerant gram negative bacteria came back below 1,000 CFU per gram. Chocolate Protein Powder, lot LOT241103. Tested by Certified Laboratories, an A2LA ISO 17025 accredited testing laboratory operating under certificate number 3034.01. Heavy metals by ICP-MS: arsenic at 0.020 parts per million, cadmium at 0.096 ppm, lead at 0.032 ppm, and mercury not detected against a method detection limit of 0.001 ppm. Microbiological testing returned total plate count below 10 CFU per gram, yeast and mold below 10 CFU per gram, no growth on enrichment, and absence of coliforms, E. coli, Pseudomonas, S. aureus, Salmonella, and Candida albicans. Chocolate Collagen Protein, lot LOT 112105. Also Certified Laboratories. Lead at 0.212 ppm, arsenic at 0.012 ppm, cadmium at 0.044 ppm, mercury not detected. Full microbiological panel returned the same clean results as above across every marker. Electrolytes, both flavors. Lemon-Lime, lot B2CE85, and Raspberry, lot 14EAF7, were each tested separately rather than one result being applied to both. Lemon-Lime heavy metals: lead 0.051 ppm, arsenic 0.024 ppm, cadmium 0.003 ppm, mercury 0.005 ppm. Raspberry: lead 0.095 ppm, arsenic 0.029 ppm, cadmium 0.004 ppm, mercury 0.002 ppm. Both flavors also received independent microbiological analysis, with total plate count and yeast and mold both below 10 CFU per gram and every pathogen marker returning absent. One honest note on these Certified Laboratories heavy metal reports: the specification column reads "Only Report," meaning the laboratory measured and disclosed the values without evaluating them against a predetermined pass or fail limit. The numbers are real and independently measured. The interpretation of whether they're acceptable was not part of what the lab was asked to determine, which is a meaningful distinction from a result reported as passing a defined specification. Tier two: manufacturer-issued documentation This tier covers our magnesium complex and creatine, and the documentation is genuinely different in character from tier one. Magnesium Complex, lot 071225. Documentation issued through Manifest Labs, manufactured December 4, 2025, best by December 2028. Every active ingredient was verified individually against its labeled amount using USP/NF current chapter 2091 methodology: magnesium glycinate at 250.0 milligrams against a 250.00 milligram specification, magnesium malate at 75.0 against 75.00, magnesium citrate at 100.0 against 100.00, magnesium L-threonate at 75.0 against 75.00, vitamin B6 as pyridoxine at 5.0 against 5.00, zinc gluconate at 10.0 against 10.00, and boron aspartate at 1.0 against 1.00. Average total capsule weight came in at 670 milligrams against a 686 milligram specification with a 10 percent tolerance, and average fill weight at 570 against 586 with the same tolerance. Microbiological results conformed across total plate count below 10,000 CFU per gram, E. coli negative in 10 grams, yeast and mold below 1,000 CFU per gram, and Salmonella negative in 25 grams, tested under USP/NF chapters 61 and 62. Excipients are rice flour and magnesium stearate. The capsule is size 0 clear gelatin. Creatine Monohydrate, lot 341125. Also through Manifest Labs, manufactured November 29, 2025, best by November 2028. Creatine monohydrate content was verified at 4,976 milligrams against a 5,000 milligram specification with 10 percent tolerance, using HPLC. Sodium came in at 39.85 milligrams against a 40.00 milligram specification by ICP-MS. Microbiological results conformed across the same four markers as the magnesium complex. No excipients. Now the honest qualifications on this tier, which we've stated in previous posts and will keep stating. The magnesium documentation carries an explicit note that the information is based on the certificate of analysis received from the supplier and is not intended as a substitute for strict quality control analysis by the customer of the product. That is a materially weaker form of documentation than independently commissioned finished-product testing, and we're not going to present it as equivalent. Additionally, neither the magnesium nor the creatine documentation includes a heavy metals panel. Both cover potency and microbial safety. Neither covers heavy metal contamination. That's a genuine gap in our current documentation for these two products, and closing it is on our list. Tier three: raw material supplier certification Shilajit powder, batch 02.00600. This is the most extensively detailed document in our entire catalog and simultaneously the one requiring the most careful framing, because it is a raw material supplier certificate rather than a finished-product test we commissioned. The material is sourced from the Kosh-Agach district of the Republic of Altai in the Russian Federation, tested against Technical Conditions 9345-037-39193650-03 and the Technical Regulations of the Customs Union on food product safety, TR CU 021/2025. The testing methods are Russian GOST standards rather than USP methods, which are legitimate national standards but a different framework from the pharmacopeial methods used elsewhere in our catalog. The results are genuinely comprehensive. Heavy metals: lead at 0.67 milligrams per kilogram against a permitted level of 6, cadmium at 0.12 against 1, arsenic at 0.08 against 12, and mercury below 0.01 against 1. Pesticide screening for heptachlor and aldrin both returned not detected against limits of 0.01. Microbiological testing found pathogenic flora including salmonella not detected in 10 grams, mesophilic aerobic and facultative anaerobic microorganisms below 1x10² against a limit of 1x10⁴, coliform bacteria not detected in 0.1 grams, Staphylococcus aureus not detected in 0.1 grams, B. cereus not detected in 200 grams, and yeast and mold not detected. The authenticity test returned "Authentic." Taste conformed to the expected bitter-tart profile and color conformed to the expected fine brown or black powder. Fulvic acid measured 72 percent, humic acid 8.3 percent, moisture 4.0 percent. Radionuclide screening for strontium specific activity returned below 3 becquerels per kilogram. The full mineral panel: potassium 42,300 milligrams per kilogram, calcium 24,800, magnesium 1,958, sodium 1,478, phosphorus 900, iron 240, aluminum 230, boron 48, manganese 40, zinc 11.50, copper 6.84, barium 5.00, lithium 3.25, molybdenum 1.23, selenium 1.20, nickel 1.07, cobalt 0.69, vanadium 0.41, silver 0.18, and lanthanum 0.17, with beryllium, tungsten, tin, bismuth, thallium, tellurium, antimony, and chromium all below detection thresholds. The vitamin panel and full amino acid profile were also measured and reported, with alanine highest at 800.5 milligrams per 100 grams, followed by tyrosine at 720.50 and proline at 620.10. That's an unusually detailed document, and the numbers are real. What it is not is a finished-product test commissioned by us from an independent US laboratory, and that distinction is worth keeping clear rather than letting the impressive level of detail obscure it. Cosmetics: a different regulatory framework Our soap, shampoo, and conditioner are cosmetics rather than dietary supplements, which means they're governed by different regulations and tested against different standards. All three were documented by Nüvue Labs against USP35-NF-30 quality standards, with attestations of compliance with FDA cosmetic regulations including the Modernization of Cosmetics Regulation Act of 2022 and Title 21 of the Code of Federal Regulations. Tallow Soap, batch D26070001, manufactured April 16, 2026: pH at 10.6 against a 10 to 12 specification, density at 1.040 grams per milliliter against a 0.904 to 1.190 range, viscosity at 11,100 against a 9,500 to 13,000 range. Total aerobic bacterial count below 10 CFU per gram against a limit of 1,000, and total mold and yeast count below 10 against a limit of 100. Shampoo, batch M25160001, manufactured April 13, 2026: pH at 5.84 against a 5.5 to 6.5 specification, density at 1.040 against 1.000 to 1.100, viscosity at 11,000 against 5,000 to 15,000. Microbial results matched the soap, below 10 CFU per gram on both markers. Conditioner, batch M25190001, manufactured January 5, 2026: pH at 5.16 against a 4.5 to 5.5 specification, density at 0.98 against 0.850 to 1.120, viscosity at 40,000 against 10,000 to 50,000. Microbial results again below 10 CFU per gram on both. The pH figures are the most practically meaningful numbers here, since hair and skin behave measurably differently depending on the pH of what's applied to them, as we've covered in detail elsewhere. One honest qualification on this tier as well: these documents carry a note that testing was performed by in-house or approved third-party laboratory, which does not fully resolve the independence question the way a named external accredited lab does. What isn't here yet Two gaps worth naming directly rather than leaving for someone to notice. Our Vitamin D3 and K2 product is not included in this recap. We are currently working through its batch documentation with the manufacturer and will publish those figures once that process is complete and we're confident in what we're presenting. We'd rather leave a gap in a transparency post than fill it with numbers we haven't fully verified. Heavy metal panels are missing from our magnesium and creatine documentation, as noted above. Both products have verified potency and microbial safety. Neither currently has heavy metal screening in the documentation we hold, and extending that coverage is the most concrete improvement available to us right now. What all of this actually means The numbers above are real and checkable against the documents they came from. What they establish is specific and bounded: these particular batches, tested on these particular dates, by these particular laboratories, using these particular methods, returned these particular results. They don't establish that every future batch will read identically, which is precisely why batch-specific documentation matters more than a single certificate published once. They don't cover every possible contaminant or quality question, since a heavy metal panel says nothing about pesticides and a potency test says nothing about microbial safety. And the strength of the documentation genuinely varies across our catalog, from independently commissioned finished-product analysis at one end to supplier-relayed raw material certification at the other. We think publishing that variation honestly is more useful than presenting a uniform impression of rigor that the underlying documents wouldn't support. If you want to see any specific document referenced here, ask and we'll send it.
Learn moreCreatine and Cognitive Function: What the Newest Research Shows
Creatine and Cognitive Function: What the Newest Research Shows Creatine's reputation has expanded rapidly over the past few years from a well-established muscle supplement into something marketed as a brain supplement, and the shift happened faster than the evidence did. The actual research picture here is one of the more instructive cases in nutrition science right now, not because the answer is simple in either direction, but because it involves a widely publicized positive meta-analysis, a serious published statistical challenge to that meta-analysis, a second meta-analysis facing the same criticism, and a formal regulatory assessment that reached a conclusion most consumers have never heard. It's also a case where one of the researchers behind the positive findings has said publicly that it's too early to draw the conclusion his own work is frequently cited to support. That's worth taking seriously. The mechanism is real, and worth understanding first The biological rationale connecting creatine to cognition isn't invented marketing. It rests on genuine, well-documented brain physiology. The brain is metabolically expensive. Despite representing a small fraction of body weight, it consumes a disproportionate share of the body's energy, and that energy is delivered as adenosine triphosphate, or ATP. Creatine's central biological role, the same one that underlies its muscle benefits, is participating in the phosphocreatine system, which allows rapid regeneration of ATP from ADP during periods of high demand. This system operates in brain tissue as well as muscle, and creatine kinase, the enzyme driving it, is present in tissues with high and fluctuating energy demands, which describes the brain accurately. From there, the hypothesis is straightforward: if supplementation can increase brain creatine stores, and if brain energy availability constrains cognitive performance under certain conditions, then supplementation might improve cognitive performance, particularly under conditions of metabolic stress. That's a coherent chain of reasoning, and it's why serious researchers have pursued this question rather than dismissing it. The critical qualifier is that each link in that chain requires evidence, and the evidence weakens considerably as you move along it. Notably, research examining whether short-term supplementation actually raises brain creatine content has produced mixed results, with at least one study finding that a seven-day protocol did not elicit improvements in brain creatine content or cognitive performance in healthy young people, suggesting this population may rely primarily on the brain's own creatine synthesis rather than dietary or supplemental intake to maintain brain creatine levels. The meta-analysis that drove the popular claim Most of the confident public messaging about creatine and cognition traces back to a specific 2023 paper: Prokopidis, Giannos, Triantafyllidis, Kechagias, Forbes, and Candow, "Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials," published in Nutrition Reviews, volume 81, issue 4, pages 416 to 427. The methodology was reasonable on its face. The authors searched PubMed, Web of Science, the Cochrane Library, and Scopus from inception through September 2021, identified 23 eligible randomized controlled trials, narrowed to 10 meeting inclusion criteria for the systematic review, and included 8 in the meta-analysis itself. The headline result: creatine supplementation improved measures of memory compared with placebo, with a standardized mean difference of 0.29, a 95 percent confidence interval of 0.04 to 0.53, heterogeneity of 66 percent, and a p-value of 0.02. The authors concluded that creatine enhanced memory performance in healthy individuals, especially in older adults aged 66 to 76. Those specific numbers deserve a closer read than they usually get. A standardized mean difference of 0.29 is a small effect by conventional interpretation. The confidence interval's lower bound of 0.04 sits very close to zero, meaning the finding is statistically significant but only barely, and a modest shift in the underlying data could move it to non-significance. And an I-squared value of 66 percent indicates substantial heterogeneity, meaning the individual studies pooled together disagreed with each other considerably, which weakens confidence that they're all measuring the same underlying effect. None of that makes the paper wrong. It makes the finding modest and fragile rather than robust, which is a meaningfully different thing than how it's typically represented. The statistical challenge Later in 2023, Nutrition Reviews published a letter to the editor by Eckert and Pascher, in volume 81, issue 11, pages 1495 to 1496, titled directly: "Double-counting due to inadequate statistics leads to false-positive findings." Their criticism concerns a specific and consequential methodological problem. Several of the individual studies included in the meta-analysis reported multiple memory subtests from the same participants. When each of those subtests is entered into a pooled analysis as if it were an independent observation, the total number of observations exceeds the number of unique randomized participants. This violates the statistical assumption that observations are independent of one another, and the documented consequence is that it artificially inflates precision and statistical power, which increases the risk of a false-positive finding. The authors of the original meta-analysis published a reply, and the exchange is available in the same journal for anyone wanting to evaluate both positions directly rather than taking either side's characterization on faith. What matters for a reader trying to assess this evidence is that the central positive finding driving most public claims about creatine and memory has faced a specific, published, methodological challenge from other researchers, and that challenge concerns the statistical foundation of the result rather than a matter of interpretation. The second meta-analysis, and the same problem A subsequent meta-analysis by Xu, Bi, Zhang, and Luo, "The effects of creatine supplementation on cognitive function in adults," was published in Frontiers in Nutrition in July 2024, volume 11, article 1424972, following PRISMA 2020 guidelines and covering randomized controlled trials published between 1993 and 2024. Two things happened to this paper worth knowing about. First, it required a formal corrigendum, published in Frontiers in Nutrition in February 2025, correcting an error in the results section on attention that the authors attributed to a translation error from Chinese to English. Corrigenda are a normal and healthy part of scientific publishing, and their existence isn't itself damning, but a correction to a results section is more consequential than a typographical fix. Second, and more substantively, a commentary published in Frontiers in Nutrition in 2026 by Citherlet raised the same double-counting criticism against this meta-analysis that Eckert and Pascher raised against Prokopidis. The commentary identified specific examples: in the memory analysis, the Alves 2013 studies each contributed at least seven memory subtests, McMorris 2006 contributed four, McMorris 2007b four, and Pires 2020 four, meaning the number of pooled observations again exceeded the number of unique randomized participants. So the two most cited meta-analyses supporting creatine's cognitive benefits have both faced published criticism for the same specific statistical problem, from independent commentators, in peer-reviewed venues. The regulatory assessment almost nobody cites In November 2024, the European Food Safety Authority's Panel on Nutrition, Novel Foods and Food Allergens published a formal scientific opinion evaluating a health claim application linking creatine supplementation to improved cognitive function. The opinion appears in the EFSA Journal, volume 22, issue 11, article e9100, authored by Turck and colleagues. The application had been filed by Alzchem Trostberg GmbH, a major creatine manufacturer, through Austria's competent authority. This matters because a regulatory health claim evaluation is a different kind of exercise than a meta-analysis. The applicant has a direct commercial incentive to present the strongest available case, submits the evidence they consider most compelling, and can respond to additional data requests, which EFSA issued twice during this evaluation. The panel then assesses whether the totality of that evidence establishes a cause-and-effect relationship. The panel evaluated 21 human intervention studies identified by the applicant, plus two additional studies identified through a meta-analysis reference list, plus a systematic review and meta-analysis of 16 randomized controlled trials submitted in response to an additional data request. Their conclusion, stated directly: a cause-and-effect relationship has not been established between creatine supplementation and an improvement in cognitive function in one or more of its domains. What EFSA specifically found The reasoning behind that conclusion is more informative than the conclusion alone. On dosing, the panel noted that acute effects on working memory were observed at daily doses of 20 grams per day, but these effects were not observed at lower doses, nor with continuous supplementation at 5 grams per day for six weeks. This is a genuinely important detail. Twenty grams per day is a loading-phase dose, roughly four times the standard maintenance dose most people take, and the effects that appeared at that level did not persist at the doses actually used in typical daily supplementation. On consistency, the panel observed that an effect on response inhibition at 20 grams per day for seven days was an isolated finding among ten intervention studies in healthy individuals, with no effects observed on other cognitive domains. A single positive result across ten studies, in one domain only, is the kind of pattern that could easily reflect chance rather than a genuine effect. On clinical populations, the three intervention studies conducted in diseased individuals did not support an effect of creatine supplementation on cognition. On mechanism, the panel considered the available evidence for a mechanism by which creatine could exert the claimed effect to be weak, notwithstanding the plausible theoretical reasoning described earlier in this post. The panel also revisited three older studies, McMorris 2006, McMorris 2007, and Rae 2003, which it had previously evaluated in a 2011 opinion on creatine and memory. Its assessment of their methodological quality was blunt: lack of information on randomization procedures, inadequate adjustment for baseline differences, multiple uncorrected pairwise comparisons or an inappropriate significance level, and insufficient detail on the statistical models used to allow scientific assessment. The panel concluded no conclusions could be drawn from those studies for substantiating the claim. Notably, several of those same studies appear in the meta-analyses discussed above. The practical consequence is that health claims linking creatine to cognitive benefits cannot be used on products marketed in the European Union. What a researcher behind the positive findings said The most striking element of this whole picture comes from Darren Candow, a co-author on the Prokopidis meta-analysis and one of the more prolific creatine researchers working today. Responding to the EFSA decision, Candow said it was justified based on the current body of research, which he described as very small. He noted that when you look closely at the studies, most of the results relate to a metabolic stressor, or the dosages used were very inconsistent. He also pointed out that no study has given creatine to individuals and then measured whether cognition remained improved after creatine withdrawal, that individual studies are underpowered, that current meta-analyses are inconsistent, and that no dosing studies using magnetic resonance spectroscopy have been performed. His summary: in his opinion, it's way too early to conclude that creatine improves cognition overall. When a researcher who co-authored a positive meta-analysis publicly agrees that a regulator was right to reject the claim his work is cited to support, that's about as clear a signal as this field produces about where the evidence actually stands. Where the signals, such as they are, appear strongest None of this means the hypothesis is dead, and the honest version includes where the more promising signals cluster. Older adults appear repeatedly as the population where effects, when detected, are most often found, which is consistent with the Prokopidis finding specifically highlighting adults aged 66 to 76. A systematic review of creatine and cognition in aging published in Nutrition Reviews in 2026 continues examining this population specifically, while noting contradictory findings across the literature and the need for further clinical studies exploring mechanism. Vegetarians are a mechanistically interesting group, since dietary creatine comes primarily from meat and fish, meaning vegetarians typically have lower baseline creatine stores and therefore more theoretical room for supplementation to matter. Research by Rae and colleagues in 45 young adult vegetarian participants reported positive effects on working memory and intelligence measures, though this study is among those EFSA specifically criticized on methodological grounds. Conditions of metabolic stress, particularly sleep deprivation, recur as a context where effects have been observed, consistent with Candow's observation that most positive results relate to a metabolic stressor rather than to baseline cognitive performance in rested, well-nourished individuals. The pattern suggests that if creatine does affect cognition, it may do so specifically by relieving a constraint in people who have one, whether from age, diet, or acute stress, rather than by enhancing performance in people who don't. That's a considerably narrower claim than "creatine improves brain function," and it's still not established. The contrast worth drawing There's a useful comparison sitting right next to this one. In 2016, EFSA approved an Article 13(5) health claim for creatine in combination with resistance training to improve muscle strength in adults over the age of 55. Same regulator, same evidentiary standard, same compound, entirely different outcome. That contrast is the most useful thing to take from all of this. Creatine's effects on muscle performance and strength are supported by decades of consistent research and have cleared one of the more demanding regulatory bars in the world. Its effects on cognition rest on a smaller body of literature, with two prominent meta-analyses facing published statistical criticism, isolated findings at loading doses that don't persist at normal doses, and a formal regulatory determination that causation has not been established. Both facts are about the same supplement. Holding them simultaneously, rather than letting the strength of one carry the other, is what accuracy requires here. The honest summary The mechanism connecting creatine to brain energy metabolism is real and plausible. The clinical evidence that supplementation improves cognitive function in healthy adults at typical doses is weak, contested, and formally judged insufficient to establish causation by EFSA in November 2024 after reviewing 21 human intervention studies. The two most-cited meta-analyses supporting cognitive benefits have both been challenged in peer-reviewed commentary for double-counting non-independent outcomes, a statistical problem known to inflate false-positive findings. One of the authors of the more prominent of those meta-analyses has publicly stated it's too early to conclude creatine improves cognition. If you take creatine, the reasons to do so remain well supported: strength, power output, recovery, and lean mass maintenance, particularly with resistance training and particularly as you age. Cognitive benefit is an interesting hypothesis with some suggestive signals in specific populations, not an established outcome, and anyone telling you otherwise is ahead of the evidence. That may change. Larger, better-powered trials with proper statistical handling, MRS-based dosing studies, and research specifically designed around the populations where signals cluster could all shift this picture. Until they do, the accurate answer is that this remains an open question, and the newest research has made the case weaker rather than stronger.
Learn more


